当前位置: 首页 > 期刊 > 《上海医药》 > 2013年第6期
编号:12355848
无创性产前诊断技术应用于21—三体综合征筛查的进展(4)
http://www.100md.com 2013年3月15日 《上海医药》 2013年第6期
     [6] Hulten MA, Old RW. Non-invasive prenatal diagnosis of Down’s syndrome [J]. Lancet, 2007, 369(9578): 1997.

    [7] Chim SS, Jin S, Lee TY, et al. Systematic search for placental DNA methylation markers on chromosome 21:toward a maternal plasma-based epigenetic test for fetal trisomy 21[J]. Clin Chem, 2008, 54(3): 500-511.

    [8] Poon LL, Leung TN, Lau TK, et al. Presence of fetal RNA in maternal plasma[J]. Clin Chem, 2000, 46(11): 1832-1834.

    [9] United Kingdom National Screening Committee. Antenatal screening–working standards for Down’s syndrome screening 2007[EB/OL].(2012-01-30)[2013-01-30]. http://fetalanomaly.screening.nhs.uk/standardsandpolicies.

    [10] Sparks AB, Struble CA, Wang ET, et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18[J]. Am J Obstet Gynecol, 2012, 206(4): 319.

    [11] Bishop AJ, Marteau TM, Armstrong D. Women and health care professionals’ preferences for Down’s syndrome screening tests: a conjoint analysis study[J]. BJOG, 2004, 111(8): 775-779.

    (收稿日期:2013-01-30)

    , 百拇医药(周奋翮 孙路明)
上一页1 2 3 4